Serono amends Rebif BLA

Serono (SRA; SWX:SEO) submitted an amendment to its BLA for Rebif recombinant interferon beta-1a to treat relapsing-remitting multiple sclerosis (RRMS). SRA said the amendment includes clinical data f...